库欣综合征的医学管理。 - Suppr

Suppr

超能文献

Medical management of Cushing's syndrome.

作者信息

Vance Mary Lee

出版信息

Endocr Pract. 2013 Mar-Apr;19(2):193. doi: 10.4158/EP12262.ED.

DOI:10.4158/EP12262.ED

PMID:23598532

Abstract

摘要

相似文献

Medical management of Cushing's syndrome.

Endocr Pract. 2013 Mar-Apr;19(2):193. doi: 10.4158/EP12262.ED.

The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome.

Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):295-9. doi: 10.1097/MED.0b013e32835430bf.

Mifepristone for management of Cushing's syndrome.

Pharmacotherapy. 2013 Mar;33(3):319-29. doi: 10.1002/phar.1202. Epub 2013 Feb 21.

A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone.

Endocr Pract. 2013 Mar-Apr;19(2):313-26. doi: 10.4158/EP12149.RA.

Mifepristone: treatment of Cushing's syndrome.

Clin Obstet Gynecol. 1996 Jun;39(2):506-10. doi: 10.1097/00003081-199606000-00024.

Medical treatment of Cushing's syndrome: glucocorticoid receptor antagonists and mifepristone.

Neuroendocrinology. 2010;92 Suppl 1:125-30. doi: 10.1159/000314224. Epub 2010 Sep 10.

The use of mifepristone in the treatment of Cushing's syndrome.

Drugs Today (Barc). 2012 Aug;48(8):509-18. doi: 10.1358/dot.2012.48.8.1841299.

Mifepristone (Korlym) for Cushing's syndrome.

Med Lett Drugs Ther. 2012 Jun 11;54(1392):46-7.

Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extension.

BMC Endocr Disord. 2015 Oct 27;15:63. doi: 10.1186/s12902-015-0059-5.

Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotide.

Expert Opin Emerg Drugs. 2012 Sep;17(3):279-83. doi: 10.1517/14728214.2012.679263. Epub 2012 Apr 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Medical management of Cushing's syndrome.

Endocr Pract. 2013 Mar-Apr;19(2):193. doi: 10.4158/EP12262.ED.

The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome.

Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):295-9. doi: 10.1097/MED.0b013e32835430bf.

Mifepristone for management of Cushing's syndrome.

Pharmacotherapy. 2013 Mar;33(3):319-29. doi: 10.1002/phar.1202. Epub 2013 Feb 21.

A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone.

Endocr Pract. 2013 Mar-Apr;19(2):313-26. doi: 10.4158/EP12149.RA.

Mifepristone: treatment of Cushing's syndrome.

Clin Obstet Gynecol. 1996 Jun;39(2):506-10. doi: 10.1097/00003081-199606000-00024.

Medical treatment of Cushing's syndrome: glucocorticoid receptor antagonists and mifepristone.

Neuroendocrinology. 2010;92 Suppl 1:125-30. doi: 10.1159/000314224. Epub 2010 Sep 10.

The use of mifepristone in the treatment of Cushing's syndrome.

Drugs Today (Barc). 2012 Aug;48(8):509-18. doi: 10.1358/dot.2012.48.8.1841299.

Mifepristone (Korlym) for Cushing's syndrome.

Med Lett Drugs Ther. 2012 Jun 11;54(1392):46-7.

Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extension.

BMC Endocr Disord. 2015 Oct 27;15:63. doi: 10.1186/s12902-015-0059-5.

Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotide.

Expert Opin Emerg Drugs. 2012 Sep;17(3):279-83. doi: 10.1517/14728214.2012.679263. Epub 2012 Apr 25.